Skip to main content

Day: June 27, 2022

Farmers National Banc Corp. and Emclaire Financial Corp. Announce Election Deadline of July 19, 2022

CANFIELD, Ohio, June 27, 2022 (GLOBE NEWSWIRE) — Farmers National Banc Corp. (“Farmers”) (NASDAQ: FMNB), the holding company for The Farmers National Bank of Canfield (“Farmers Bank”), and Emclaire Financial Corp. (“Emclaire”) (NASDAQ: EMCF), the holding company for The Farmers National Bank of Emlenton (“Emlenton Bank”), jointly announced today an election deadline of 5:00 p.m., Eastern Standard Time, July 19, 2022 (the “Election Deadline”) for shareholders of Emclaire to elect the form of consideration they wish to receive for their shares of Emclaire common stock in connection with the proposed merger (the “Merger”) of Emclaire with and into FMNB Merger Subsidiary V, LLC, a newly-formed, wholly-owned subsidiary of Farmers (“Merger Sub”), pursuant to the Agreement and Plan of Merger, dated as of March 23, 2022, by and among Farmers,...

Continue reading

Form 8.3 – [Secure Income REIT plc – 24 06 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree SECURE INCOME REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [LXi REIT plc – 24 06 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LXI REIT PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – [CareTech Holdings plc – 24 06 2022] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CARETECH HOLDINGS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Auction result of Treasury Bills – RIKV 22 0824 – RIKV 22 1019

Series  RIKV 22 0824 RIKV 22 1019Settlement Date  06/29/2022 06/29/2022Total Amount Allocated (MM)  32,250 2,700All Bids Awarded At (Price / Simple interest)  99.213 / 5.099 98.273 / 5.649Total Number of Bids Received  19 5Total Amount of All Bids Received (MM)  32,550 2,700Total Number of Successful Bids  17 5Number of Bids Allocated in Full  17 5Lowest Price / Highest Simple Interest Allocated  99.213 / 5.099 98.273 / 5.649Highest Price / Lowest Simple Interest Allocated  99.267 / 4.747 98.378 / 5.300Lowest Price / Highest Simple Interest Allocated in Full  99.213 / 5.099 98.273 / 5.649Weighted Average of Successful Bids (Price/Simple Interest)  99.241 / 4.917 98.316 / 5.506Best Bid (Price / Simple Interest)  99.267 / 4.747 98.378 / 5.300Worst Bid (Price / Simple Interest)  99.198 / 5.197 98.273 / 5.649Weighted...

Continue reading

Meso Numismatics and Global Stem Cell Group Expand its Global Footprint

LAS VEGAS, NV, June 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a technology company specializing in Biotech and Numismatics, is pleased to announce that its wholly owned subsidiary Global Stem Cells Group has completed the signing of an exclusive 5-year contract with Ramzan Ali Stem Cell Center to expand the company’s service for patients, doctors and product lines into Pakistan, the world’s 5th most populous healthcare market. “This partnership seeks to expand the Global Stem Cell Group (GSCG) brand by creating centers of excellence in cell therapy to meet the demand in the Asian and Middle Eastern markets,” said David Christensen, CEO of MSSV. “GSCG is rapidly expanding its operations globally as it seeks to be a significant player in the lucrative...

Continue reading

Jushi Holdings Inc. Announces Share Purchase by Chief Executive Officer, Chairman, and Founder, Jim Cacioppo

BOCA RATON, Fla., June 27, 2022 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that Chief Executive Officer, Chairman, and Founder, Jim Cacioppo, has purchased 100,000 Class B Subordinate Voting Shares (“Shares”) of the Company in the open market for an approximate amount of $151,000. Mr. Cacioppo holds in the aggregate approximately 16.9% of the issued and outstanding Subordinate Voting Shares (calculated in accordance with National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and on a non-diluted basis). Jim Cacioppo, Chief Executive Officer, Chairman, and Founder of Jushi, stated, “I am confident in our growth strategy and long-term outlook and have increased...

Continue reading

Verisk Named One of the 2022 Best Workplaces in New York™ by Fortune Magazine and Great Place to Work® for Second Consecutive Year

JERSEY CITY, N.J., June 27, 2022 (GLOBE NEWSWIRE) — Fortune magazine and Great Place to Work have honored Verisk (Nasdaq: VRSK) as one of the Best Workplaces in New York for the second consecutive year. The award recognizes Verisk, a leading global data analytics provider, for its outstanding workplace culture of engagement through education and development, team collaboration and open communication. The Best Workplaces in New York award is based on employee feedback collected through America’s largest ongoing annual workforce study of over 1 million employee survey responses and data from companies representing more than 6.1 million U.S. employees. In that survey 83% of Verisk’s employees said Verisk is a great place to work, compared to 57% of employees at the average U.S.-based company. “In today’s rapidly-evolving landscape,...

Continue reading

nCino Hires Chief People Officer to Lead Company’s Strategic People Functions Through Next Phase of Global Growth and Maturation

WILMINGTON, N.C., June 27, 2022 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking and digital transformation solutions for the global financial services industry, today announced that Chris Ainsworth has joined the Company as its first Chief People Officer, serving as a member of the nCino Executive Leadership Team. “At nCino, one of our highest priorities and most valuable assets has and will continue to be our people,” said Pierre Naudé, Chairman and Chief Executive Officer of nCino. “Chris brings to nCino more than two decades of experience and a proven track record of leading high-performing human resources and talent teams in complex global financial organizations. I am confident his knowledge and perspective will enable us to continue attracting, hiring, developing and retaining the best people in...

Continue reading

TG Therapeutics Announces Presentation of Exploratory Analyses from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at the 8Th Congress of the European Academy of Neurology

NEW YORK, June 27, 2022 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced data presentations highlighting data from pooled and post hoc analyses of the ULTIMATE I & II Phase 3 trials evaluating ublituximab in patients with relapsing forms of multiple sclerosis (RMS), presented at the 8th Congress of the European Academy of Neurology (EAN). Links to the presentations are included below. Michael S. Weiss, Chairman and Chief Executive Officer of TG Therapeutics stated, “We are encouraged by the findings from these additional exploratory analyses of the ULTIMATE I & II Phase 3 trials, which reinforces our belief in the potential of ublituximab in the treatment of relapsing forms of multiple sclerosis. As a company, our primary focus remains on obtaining FDA approval of ublituximab by December 28, 2022,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.